Free Daily Podcast Summary
ATTD: Advanced Technologies and Treatments for Diabetes: Daily Summaries Delivered
by ATTD on UNLOK
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago18 min
The Weekly Insulin Breakthrough
In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin, we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management.Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health System)Key Topics Covered:The Evolution of Basal Insulin: A look back at the progression from early long-acting formulations to current weekly treatment options.Pharmacological Innovation: Understanding the science that makes weekly insulin formulations possible.Clinical Advantages: Exploring the theoretical benefits of weekly versus daily basal insulin.Patient Impact: Examining how shifting to a weekly regimen affects treatment burden and overall patient experience.Future Outlook: How weekly insulin is poised to fit into the broader landscape of diabetes care.Resources:For more in-depth knowledge and exclusive content, visit the ATTD Education Portal.Subscribe to the podcast to stay updated on the latest in diabetes management.
- 3 weeks ago24 min
Unmet needs in paediatric diabetes – the potential role of inhaled insulin
Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populationsIn this final episode, we dive into:Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth.The INHALE-1 Study: A deep dive into the randomized controlled trial data of 230 youth, highlighting efficacy, per-protocol non-inferiority, less weight gain, and superior treatment satisfaction among kids and parents.Safety Profile: Analyzing forced expiratory volume (FEV1) data showing an excellent safety signal with no differences in pulmonary function or severe hypoglycemic events.Practical Toolkit Use Cases: How the unique pharmacokinetic profile of inhaled insulin provides unmatched benefits for covering adrenaline-rush highs and avoiding hypoglycemia tail effects during sports and exercise.Dosing Guidelines: Overcoming the practical "paradigm shift" of converting injected units to inhaled units and managing dosing effectively.Future Horizons: Anticipating the "INHALE FIRST" study investigating early onboarding for newly diagnosed patients and introducing a new two-unit inhaled insulin cartridge.About ATTD Diabetes Talks:A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/Subscribe to the podcast for more updates on advancing diabetes care.#DiabetesManagement #PediatricEndocrinology #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Type1DiabetesChapters:00:00 Intro and Unique Challenges in Pediatric Diabetes Management02:38 The INHALE-1 Study: Efficacy, Satisfaction, and Weight Findings06:27 Safety Signals, Pulmonary Function, and Adherence Challenges10:18 Practical Toolkit Use Cases: Managing Sports and Exercise12:48 Dosing Conversions and Practical Patient Selection Guidelines15:02 Off-Label Integration with Automated Insulin Delivery (AID) Systems20:14 Caregiver & School Nurse Roles and Managing Safety Concerns22:00 Research Gaps, The INHALE FIRST Trial, and Wrap Up
- Aug 18, 202621 min
Use of inhaled insulin with automated insulin delivery (AID) systems
Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems.In this episode, we dive into:The potential of combining inhaled insulin with current AID technologies.Theoretical advantages, including postprandial management.Current evidence, clinical considerations, and existing evidence gaps.Practical insights for clinicians on patient education and system integration.About ATTD Diabetes Talks:A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation.Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/Subscribe to the podcast for more updates on advancing diabetes care.#DiabetesManagement #AIDSystems #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #EndocrinologyChapters:00:00 Intro03:03 How Inhaled Insulin Works07:30 Real World Dosing Workflow10:24 Exercise and Safety Upside15:45 Clinician Education Tips17:38 Research Gaps and Trials Needed19:32 Future Potential and Wrap Up
- Aug 11, 202616 min
Overcoming therapeutic inertia with inhaled insulin
In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.Key discussion points:Defining therapeutic inertia in the context of insulin initiation.Common clinician and patient-related barriers that contribute to treatment delays.Practical strategies for introducing inhaled insulin to hesitant patients.System-level considerations, including workflow and reimbursement challenges.Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcastChapters:00:00 Why Inhaled Insulin Matters00:34 Show Intro and Guest01:22 Defining Therapeutic Inertia02:19 Clinician Barriers to Insulin03:49 Patient Fears and Hesitation05:28 How Inhaled Insulin Helps07:00 Best Fit Patient Scenarios08:22 Talking to Hesitant Patients10:39 Workflow and Coverage Hurdles13:35 PFT Testing and Side Effects14:47 Future Role and Wrap Up
- Aug 4, 202629 min
Practical implementation of inhaled insulin in clinical practice
In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch.They discuss:Where inhaled insulin fits today within the overall insulin therapy landscapeThe best candidates for inhaled insulin in routine clinical practiceKey clinical factors to guide decision-makingPractical first steps to initiating inhaled insulinApproaches to titrationMonitoring strategies, particularly regarding pulmonary safety and glycemic outcomesShared decision-making and engaging patientsDr Irl Hirsch is Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington School of Medicine. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
- Jul 28, 202616 min
Addressing Clinicians’ FAQs on Insulin Therapy
In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy.They discuss:The most common mistakes or misconceptions in basal insulin initiation and managementIntensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinationsLeveraging technologies to improve insulin adherence and outcomesManaging hypoglycemia concerns and achieving glycemic targetsAddressing psychological and behavioral barriers to insulin use in everyday clinical practiceDr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
- Jul 14, 202614 min
Personalised Approaches for Complex Populations
In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations.They discuss:Why personalization is particularly important in insulin therapyThe patient groups most in need of a tailored approachHow comorbidities or frailty influence insulin decision-makingGuidelines, flexibility, and local solutionsDr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
- Jun 30, 202618 min
Overcoming Barriers to Insulin Adherence
In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients.They discuss:The barriers most misunderstood by cliniciansCommunication and motivational interviewing with patientsEmotional burden and fear of hypoglycemiaPractical strategies clinicians can use to support patients more effectivelyThe role of the wider diabetes healthcare teamDiana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
About ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from ATTD: Advanced Technologies and Treatments for Diabetes in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's ATTD: Advanced Technologies and Treatments for Diabetes daily summary?
It's a free AI-powered email that summarizes new episodes of ATTD: Advanced Technologies and Treatments for Diabetes as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the ATTD: Advanced Technologies and Treatments for Diabetes podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official ATTD: Advanced Technologies and Treatments for Diabetes product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by ATTD on UNLOK.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does ATTD: Advanced Technologies and Treatments for Diabetes release new episodes?
ATTD: Advanced Technologies and Treatments for Diabetes publishes daily. Our AI generates a summary within hours of each new episode.
What topics does ATTD: Advanced Technologies and Treatments for Diabetes cover?
ATTD: Advanced Technologies and Treatments for Diabetes covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting ATTD: Advanced Technologies and Treatments for Diabetes summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.